DNM3OS Facilitates Ovarian Cancer Progression by Regulating miR-193a-3p/MAP3K3 Axis
Open Access
- 1 January 2021
- journal article
- research article
- Published by XMLink in Yonsei Medical Journal
- Vol. 62 (6) , 535-544
Abstract
He L, et al. Yonsei Med J. 2021 Jun;62(6):535-544. https://doi.org/10.3349/ymj.2021.62.6.535Keywords
This publication has 36 references indexed in Scilit:
- Cancer-associated Fibroblast–promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell CarcinomaClinical Cancer Research, 2019
- miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cellsInternational Journal of Molecular Medicine, 2018
- MiR‐194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expressionFEBS Open Bio, 2018
- Aberrant high expression level of MORC2 is a common character in multiple cancersHuman Pathology, 2018
- MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional ActivityAnticancer Research, 2018
- Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathwaysTheranostics, 2018
- Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transitionNature Communications, 2017
- An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancerOncology Reports, 2016
- MAP3K3 overexpression is associated with poor survival in ovarian carcinomaHuman Pathology, 2015
- MEKK3 expression correlates with nuclear factor κ B activity and with expression of antiapoptotic genes in serous ovarian carcinomaCancer, 2009